| Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasia W Duddy, S Duguez, H Johnston, TV Cohen, A Phadke, ... Skeletal muscle 5, 1-18, 2015 | 135 | 2015 |
| Molecular and cellular mechanisms affected in ALS L Le Gall, E Anakor, O Connolly, UG Vijayakumar, WJ Duddy, S Duguez Journal of personalized medicine 10 (3), 101, 2020 | 114 | 2020 |
| Age-associated methylation suppresses SPRY1, leading to a failure of re-quiescence and loss of the reserve stem cell pool in elderly muscle A Bigot, WJ Duddy, ZG Ouandaogo, E Negroni, V Mariot, S Ghimbovschi, ... Cell reports 13 (6), 1172-1182, 2015 | 106 | 2015 |
| Optimizing exon skipping therapies for DMD T Yokota, W Duddy, T Partridge Acta myologica 26 (3), 179, 2007 | 93 | 2007 |
| Skeletal muscle characteristics are preserved in hTERT/cdk4 human myogenic cell lines M Thorley, S Duguez, EMC Mazza, S Valsoni, A Bigot, K Mamchaoui, ... Skeletal muscle 6, 1-12, 2016 | 81 | 2016 |
| A systematic review of suggested molecular strata, biomarkers and their tissue sources in ALS UG Vijayakumar, V Milla, MY Cynthia Stafford, AJ Bjourson, W Duddy, ... Frontiers in Neurology 10, 400, 2019 | 79 | 2019 |
| Quantitative antisense screening and optimization for exon 51 skipping in Duchenne muscular dystrophy Y Echigoya, KRQ Lim, N Trieu, B Bao, BM Nichols, MC Vila, JS Novak, ... Molecular Therapy 25 (11), 2561-2572, 2017 | 77 | 2017 |
| Dystrophin deficiency leads to disturbance of LAMP1-vesicle-associated protein secretion S Duguez, W Duddy, H Johnston, J Lainé, MC Le Bihan, KJ Brown, ... Cellular and Molecular Life Sciences 70, 2159-2174, 2013 | 76 | 2013 |
| Mimicry by asx‐and ST‐turns of the four main types of β‐turn in proteins WJ Duddy, JWM Nissink, FH Allen, EJ Milner‐White Protein Science 13 (11), 3051-3055, 2004 | 73 | 2004 |
| Activation of Notch Signaling During Ex Vivo Expansion Maintains Donor Muscle Cell Engraftment MH Parker, C Loretz, AE Tyler, WJ Duddy, JK Hall, BB Olwin, ID Bernstein, ... Stem Cells 30 (10), 2212-2220, 2012 | 70 | 2012 |
| In Silico Screening Based on Predictive Algorithms as a Design Tool for Exon Skipping Oligonucleotides in Duchenne Muscular Dystrophy Y Echigoya, V Mouly, L Garcia, T Yokota, W Duddy PLoS One 10 (3), e0120058, 2015 | 62 | 2015 |
| Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy T Yokota, E Pistilli, W Duddy, K Nagaraju Expert opinion on biological therapy 7 (6), 831-842, 2007 | 60 | 2007 |
| A systematic review of genotype–phenotype correlation across cohorts having causal mutations of different genes in ALS O Connolly, L Le Gall, G McCluskey, CG Donaghy, WJ Duddy, S Duguez Journal of Personalized Medicine 10 (3), 58, 2020 | 57 | 2020 |
| Annexin A2 links poor myofiber repair with inflammation and adipogenic replacement of the injured muscle A Defour, S Medikayala, JH Van der Meulen, MW Hogarth, N Holdreith, ... Human molecular genetics 26 (11), 1979-1991, 2017 | 55 | 2017 |
| Exon skipping for nonsense mutations in Duchenne muscular dystrophy: too many mutations, too few patients? T Yokota, W Duddy, Y Echigoya, H Kolski Expert opinion on biological therapy 12 (9), 1141-1152, 2012 | 44 | 2012 |
| Exons 45–55 skipping using mutation-tailored cocktails of antisense morpholinos in the DMD gene Y Echigoya, KRQ Lim, D Melo, B Bao, N Trieu, Y Mizobe, R Maruyama, ... Molecular Therapy 27 (11), 2005-2017, 2019 | 43 | 2019 |
| Recurring main-chain anion-binding motifs in short polypeptides: nests EJ Milner-White, JWM Nissink, FH Allen, WJ Duddy Acta Crystallographica Section D: Biological Crystallography 60 (11), 1935-1942, 2004 | 40 | 2004 |
| Identification of novel antisense-mediated exon skipping targets in DYSF for therapeutic treatment of dysferlinopathy JJA Lee, R Maruyama, W Duddy, H Sakurai, T Yokota Molecular Therapy-Nucleic Acids 13, 596-604, 2018 | 35 | 2018 |
| Muscle cells of sporadic amyotrophic lateral sclerosis patients secrete neurotoxic vesicles L Le Gall, WJ Duddy, C Martinat, V Mariot, O Connolly, V Milla, E Anakor, ... Journal of cachexia, sarcopenia and muscle 13 (2), 1385-1402, 2022 | 31 | 2022 |
| Exosomes in ageing and motor neurone disease: biogenesis, uptake mechanisms, modifications in disease and uses in the development of biomarkers and therapeutics E Anakor, L Le Gall, J Dumonceaux, WJ Duddy, S Duguez Cells 10 (11), 2930, 2021 | 31 | 2021 |
Stephanie DuguezNorthern Ireland Center for Stratified Medicine在 ulster.ac.uk 的电子邮件经过验证
